The recent news coming out of India is cause for excitement amongst those interested in male contraception. Dr. Sujoy Guha and the rest of the RISUG team reported completing clinical trials in humans on the subcontinent, paving the way for access to the long-acting male contraceptive in India. News reports are saying that RISUG is now just waiting on final approvals from the Indian government, and that production could begin in as little as 6-7 months.
0 Comments
|
Archives
March 2021
Categories
All
|